Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- ChecktodayChange DetectedRevision: v3.4.2 has been added. The previous lapse-in-funding notice and Revision: v3.4.1 text were removed.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check15 days agoChange DetectedA 'Show glossary' option was added, QC criteria and FEAR Act data labels were updated (capitalization changes), and the revision tag now shows v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a metadata revision; no study content was changed.SummaryDifference0.1%

- Check50 days agoChange DetectedLocations are consolidated under a single Locations section listing multiple Chinese regions (Beijing Municipality, Guangdong, Heilongjiang, Jiangsu, Jiangxi, Shanghai Municipality, Zhejiang). The HHS Vulnerability Disclosure link was removed and a new revision tag v3.3.3 was added.SummaryDifference0.8%

- Check78 days agoChange DetectedThe Publications section text was updated to clarify that publications are auto-filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.